Lataa...
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
Data from two open-label trials (PRIOR and CURRENT) of women with postmenopausal osteoporosis or osteopenia were evaluated to assess whether monthly oral and quarterly intravenous (IV) ibandronate dosing improved self-reported gastrointestinal (GI) tolerability for patients who had previously experi...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2762360/ https://ncbi.nlm.nih.gov/pubmed/19851511 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|